A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
2010

Comparing Insulin Types for Type 2 Diabetes Management

Sample size: 8009 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gordon J, Pockett R D, Tetlow A P, McEwan P, Home P D

Primary Institution: School of Population Health and Clinical Practice, University of Adelaide

Hypothesis

What are the outcomes of different insulin preparations in people with type 2 diabetes starting insulin therapy?

Conclusion

People starting on NPH insulin had a modest disadvantage in glycaemic control compared to other insulins, with glargine showing the best HbA1c reduction.

Supporting Evidence

  • Insulin therapy led to a significant reduction in HbA1c levels after 12 months.
  • Patients on glargine had the best reduction in HbA1c compared to NPH.
  • Weight gain was observed across all insulin types, with the highest gain in the premix group.
  • Persistence with therapy was highest for premix insulin.

Takeaway

This study looked at how different types of insulin help people with diabetes. It found that some insulins work better than others for lowering blood sugar.

Methodology

This was a retrospective observational study using data from a UK primary care database, analyzing changes in HbA1c, body weight, and insulin doses over 12 months.

Potential Biases

Unknown biases may affect which patients received which type of insulin.

Limitations

The study may have biases due to the observational nature and the reliance on patient-reported hypoglycaemia.

Participant Demographics

Participants were insulin-naïve adults with type 2 diabetes, aged 35 and older.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1111/j.1742-1241.2010.02520.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication